迪卡特对中枢神经系统的毒理影响以及相关的治疗挑战
Xinyu Wang1, Yunxia Liu1, Meng Yang1
1Department of Emergency Medicine, Shengjing Hospital of China Medical University, Tiexi District, No. 39 Huaxiang Road, Shenyang, Liaoning 110000, PR China.
Neurotoxicology
|September 27, 2025
概括
迪卡特除草剂通过氧化应激,炎症和其他分子通路引起严重的中枢神经系统 (CNS) 损伤. 了解这些机制对于开发有效的神经保护策略来预防二中毒至关重要.
科学领域:
- 神经科学是一个神经科学.
- 毒理学 毒理学 毒理学
- 药理学 药理学是指药理学的学科.
背景情况:
- 迪卡特是一种高度有毒的除草剂,具有显著的中枢神经系统 (CNS) 毒性.
- 迪卡特中毒导致高死亡率和不良的神经结果.
- 中枢神经系统损伤和神经保护的分子机制尚不清楚.
研究的目的:
- 系统地审查和整合当前关于二引发的中枢神经系统毒性的知识.
- 为了确定底层的分子机制diquat的神经毒性.
- 突出神经保护和治疗的挑战和未来方向.
主要方法:
- 系统的文献搜索和选424个检索的记录.
- 包括21篇文章 (11篇实验,10篇案例研究).
- 系统性审查方法整合了基础研究和临床证据.
主要成果:
- 确定了临床表现 (意识受损,,脑干症状) 和成像发现 (基底腺,脑干病变).
- 突出了六个关键的分子机制:氧化应激,神经炎症,自功能障碍,亡,线粒体功能障碍和神经递质变化.
- 这些机制相互关联,导致神经元死亡和功能障碍.
结论:
- 迪奎特通过多个相互关联的分子通路诱导严重的中枢神经系统损伤.
- 目前的治疗方法因缺乏特定的抗药物和向的神经保护剂而受到挑战.
- 未来的研究应该专注于阐明机制,确定神经保护性点,优化治疗和康复策略.
相关概念视频
Anticholinesterase Agents: Poisoning and Treatment
1.5K
Anticholinesterases, also known as cholinesterase inhibitors, work by blocking the breakdown of acetylcholine, leading to its accumulation in the synaptic cleft. This accumulation indirectly enhances both muscarinic and nicotinic actions. These agents are classified as reversible or irreversible based on their mechanism of action.
Irreversible agents form a strong bond with the cholinesterase enzyme, making it inactive. The breakdown of the phosphorylated enzyme is...
Irreversible agents form a strong bond with the cholinesterase enzyme, making it inactive. The breakdown of the phosphorylated enzyme is...
1.5K
Toxic Reactions: Overview
1.8K
When toxic substances penetrate the human body, they disseminate to various tissues, undergoing metabolic changes. This process yields reactive metabolites that may covalently bind with specific target molecules, resulting in toxicity.
Toxicity falls into two primary categories: local and systemic.
Local toxicity appears at the exposure site, such as protein denaturation caused by caustic substances.
In contrast, systemic toxicity requires the toxic agent's absorption and distribution,...
Toxicity falls into two primary categories: local and systemic.
Local toxicity appears at the exposure site, such as protein denaturation caused by caustic substances.
In contrast, systemic toxicity requires the toxic agent's absorption and distribution,...
1.8K
Prevention of Further Absorption of Poison
1.2K
In cases of acute poisoning, the primary objective is to prevent further absorption of the toxic substance into the body. Immediate interventions using various decontamination techniques targeting the gastrointestinal (GI) tract can achieve this. Decontamination is crucial to prevent poison from entering the systemic circulation, which involves washing affected areas with water and mild soap and removing contaminated clothing. Once external decontamination is done, attention must be turned to...
1.2K
Depolarizing Blockers: Pharmocokinetics
567
Depolarizing blockers are administered through intravenous injection. Succinylcholine is the most common choice of depolarizing blockers in emergency clinical practices. Although they have a rapid onset, they readily diffuse away from the motor end plate into the extracellular fluid. They are metabolized by enzymes such as liver butyrylcholinesterase and plasma pseudocholinesterases. This produces a short duration of action, typically 5-10 minutes long, unlike nondepolarizing blockers, which...
567
Antidotes
1.0K
Antidotes are medicinal substances used to counteract the harmful effects of toxins or drugs in the body. They function in various ways, each uniquely designed to combat specific toxic compounds.
Specific antidotes operate by inhibiting the enzymes that control biochemical pathways, reducing the production of harmful metabolites.
An example of an antidote is atropine, which counteracts the detrimental effects of cholinesterase inhibitors. It achieves this by deactivating muscarinic receptors,...
Specific antidotes operate by inhibiting the enzymes that control biochemical pathways, reducing the production of harmful metabolites.
An example of an antidote is atropine, which counteracts the detrimental effects of cholinesterase inhibitors. It achieves this by deactivating muscarinic receptors,...
1.0K
Parkinson's Disease: Treatment
986
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
986


